In patients with chronic diseases, such as ILD and asthma, we found that CXCL9 levels were lower than those observed in samples from patients infected with COVID-19; however, some patients had CXCL9 levels exceeding the upper limit of the CXCL9 level in HCs. Here, CXCL9 is linked to asthma.